Publications

Surfacing Disparities in care management to improve outcomes for all patients.

Duke and Navigating Cancer researchers aimed to describe sociodemographic correlates of patient-reported pain among H&N cancer patients receiving care in the community setting. The study found one-in-six HNC patients in the community oncology setting reported pain, and while there were no racial differences in any pain report, white patients were significantly more likely to receive new pain prescriptions, as were those with Medicare or commercial insurance.

Identifying ways to improve digital access among minority communities

Genentech and Navigating Cancer researchers analyzed data from more than 200K people living with cancer, found that most communities of color have limited access and online communication with oncologists on digital health platforms. 

A collaboration with Texas Oncology to realize the benefits of ePROs: Dancing the Texas Two-Step through a global pandemic.

In a study of real-world ePRO implementation, Texas Oncology targeted cancer patients initiating systemic therapy to enroll in the Health Tracker ePRO digital monitoring program. The process included patient screening, introduction to the program, enrollment, initiation, observation, and intervention through the triage board workflow. There was a 65% ePRO compliance rate in the 4375 patients enrolled, as well as high participation rates among patients 65 years and older, those completing ePROs via text message, and patients on oral treatment.

In collaboration with oncology clinics, cancer research institutes, and life science partners, we innovate in key areas to enable advancements in symptom management to improve patient outcomes.

Enhance clinical care through the development of products for cancer patients

Contribute to clinical research incorporating patient reported outcomes (PROs) data.

Power population health analytics for identifying at-risk patients and providing timely interventions.

Publications

Sociodemographic differences in patient-reported pain and pain management of head and neck cancer patients in a community oncology setting.

Availability

J Clin Oncol 39, 2021 (suppl 28; abstr 150)

RESEARCH OBJECTIVE

There are currently 500,000 head and neck cancer (HNC) survivors in the United States. Pain is common among survivors and associated with adverse quality of life and outcomes. There is however a lack of data on pain management in the community oncology setting, where a growing number of patients may be receiving long-term care. We described sociodemographic correlates of patient-reported pain among HNC patients receiving care in the community setting.

Authors

Nosayaba Osazuwa-Peters, Rylan Larsen, Amila Patel, Sanjit Misra, Ben Pearson, Blaine Smith, Julia Canick, Duaa Kuziez, Rebecca L Rohde

When oncology care goes digital: A closer look at disparities.

Availability

J Clin Oncol 39, 2021 (suppl 28; abstr 119)

RESEARCH OBJECTIVE

Oncology providers are increasingly integrating digital solutions, such as patient relationship management (PRM), to improve patient care. PRM enables patients to communicate with their clinic, view health records, receive educational materials and submit patient-reported outcomes (ePROs). However, disparities in PRM adoption and engagement in oncology care are unclear.

Authors

Jad Habouch, Adit Mane

Patient and clinician perceptions of a digital patient monitoring program in the community oncology setting: Findings from the Texas Two-Step Study.

Availability

J Clin Oncol 39, 2021 (suppl 28; abstr 189)

RESEARCH OBJECTIVE

Digital monitoring strategies that include electronic patient reported outcomes (ePRO) measures to monitor symptoms among cancer patients have been shown to be effective in improving patient outcomes in a large academic setting and across several smaller multi-center trials. However, demonstration of clinical utility in the real-world setting must incorporate patient and provider perspectives of ePRO programs to ensure successful implementation.We sought to understand perceptions among patients and clinicians in our ePRO digital symptom monitoring program.

Authors

Debra A. Patt, Amila Patel, Lalan S. Wilfong, Holly Books, Lance Ortega, Max Franklin, Sarah Croft, Angela M. Stover, Rhonda Boren, Ethan M. Basch

Implementation of electronic patient-reported outcomes for symptom monitoring in a large multi-site community oncology practice: Dancing the Texas Two-Step through a global pandemic. 

Availability

American Society of Clinical Oncology (2021) 12103

RESEARCH OBJECTIVE

This Texas Two-Step study, a two-part (hybrid) implementation-effectiveness evaluation of Navigating Cancer’s ePRO digital monitoring tool with a stepped-wedge design, will assess both patient and organization-level outcomes at Texas Oncology, a large community oncology practice, according to the RE-AIM framework – reach, effectiveness, adoption, implementation, and maintenance. 

Authors

Debra A. Patt, Lalan S. Wilfong, Kathryn Elizabeth Hudson, Amila M. Patel, Holly Books, Lance Ortega, Ben Pearson, Rhonda Boren, Shrutika Patil, Kristin Olson-Celli, Ethan M. Basch

Implementation of an Electronic Patient Management Solution at a Community Oncology Practice.

Availability

American Society of Clinical Oncology (2021)

RESEARCH OBJECTIVE

In order to assess our own healthcare resource utilization, Texas Oncology embarked on a quality initiative and found that most ED visits occurred during regular business hours. Prolonged patient call back times were consistently rated poorly on satisfaction surveys and often led to ED visits for symptoms that could be managed in our offices. Initially we had no insight into call back times. We then partnered with Navigating Cancer (NC) to implement an electronic patient management technology solution with the goal of improving symptom resolution while also providing a tool to minimize staff burden.

Authors

Lalan S. Wilfong, Amila M. Patel, Lance Ortega, Rhonda Boren, Ben Pearson, Terry Lynn Jensen, Holly Books, Kathryn Elizabeth Hudson, Debra A. Patt

Interested in learning more about Navigating Cancer’s ePRO data-driven solutions?

This field is for validation purposes and should be left unchanged.